Oxycodone

2005/05/01 by Eija Kalso · 260 citations
Medicine · #Analgesic #Anesthesia #Cancer #Cancer pain #Internal medicine #Medicine #Morphine #Neuropathic pain #Opioid #Opioid Use Disorder Treatment #Osteoarthritis #Oxycodone #Pain Management and Opioid Use #Pain Mechanisms and Treatments #Pain ladder #Pharmacodynamics #Pharmacokinetics #Pharmacology #Postherpetic neuralgia

paper · doi:10.1016/j.jpainsymman.2005.01.010

published in Journal of Pain and Symptom Management 29(5), 47-56 (Elsevier BV)

crossref issued 2005/05/01 · crossref published 2005/05/01 · crossref published-print 2005/05/01 · openalex publication_date 2005/05/01 · crossref created 2005/06/15 · openalex created_date 2016/06/24 · crossref deposited 2025/10/10 · crossref indexed 2026/06/02 · openalex updated_date 2026/08/06

Citations

• Inhibition by fluoxetine of cytochrome P450 2D6 activity
• The intrinsic antinociceptive effects of oxycodone appear to be κ -opioid receptor mediated
• Analgesic Efficacy of Controlled‐Release Oxycodone in Postoperative Pain

Cited by

• Oxycodone controlled release in cancer pain management
• Fixed-ratio combination oxycodone/naloxone compared with oxycodone alone for the relief of opioid-induced constipation in moderate-to-severe noncancer pain
• Oxycodone [wikipedia]